David Brian O'GOrman

David Brian O'GOrman

Auto-generated profile, based on publicly available information

David Brian O'GOrman

Department of Biochemistry, University of Western Ontario, London, Canada

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2015 in Experimental Dermatology
Verified
Journal Article
Closed access
PDF file
JCJustin Crawford
Justin Crawford
KNKaren Nygard
Karen Nygard
BGBing Siang Gan
Bing Siang Gan
DODavid Brian O'GOrman
David Brian O'GOrman

1 December 2009 in Experimental Cell Research
Verified
Journal Article
Closed access
LVLinda Vi
Linda Vi
LFLucy Feng
Lucy Feng
RZRebecca D. Zhu
Rebecca D. Zhu
YWYan Wu
Yan Wu
LSLatha Satish
Latha Satish
DODavid B. O'GOrman
David B. O'GOrman

1 October 2018 in Journal of Shoulder and Elbow Surgery
Verified
Journal Article
Closed access
BQBoyang Qiu
Boyang Qiu
KAKait Al
Kait Al
APAna M. Pena-Diaz
Ana M. Pena-Diaz
GAGeorge S. Athwal
George S. Athwal
DDDarren Drosdowech
Darren Drosdowech
DODavid B. O'GOrman
David B. O'GOrman

23 April 2008 in BMC Medical Genomics
Verified
Journal Article
Open access
PDF file
LSLatha Satish
Latha Satish
WLWilliam LaFramboise
William LaFramboise
DODavid B O'Gorman
David B O'Gorman
SJSandra Johnson
Sandra Johnson
BJBenjamin Janto
Benjamin Janto
SKSandeep Kathju
Sandeep Kathju
Dupuytren's contracture (DC) is the most common inherited connective tissue disease of humans and is hypothesized to be associated with aberrant wound healing of the palmar fascia. Fibroblasts and myofibroblasts are believed to play an important role in the genesis of DC and the fibroproliferation and contraction that are hallmarks of this disease. This study compares the gene expression profiles of fibroblasts isolated from DC patients and controls in an attempt to identify key genes whose regulation might be significantly altered in fibroblasts found within the palmar fascia of Dupuytren's patients. Total RNA isolated from diseased palmar fascia (DC) and normal palmar fascia (obtained during carpal tunnel release; 6 samples per group) was subjected to quantitative analyses using two different microarray platforms (GE Code Link™ and Illumina™) to identify and validate differentially expressed genes. The data obtained was analyzed using The Significance Analysis of Microarrays (SAM) software through which we identified 69 and 40 differentially regulated gene transcripts using the CodeLink™ and Illumina™ platforms, respectively. The CodeLink™ platform identified 18 upregulated and 51 downregulated genes. Using the Illumina™ platform, 40 genes were identified as downregulated, eleven of which were identified by both platforms. Quantitative RT-PCR confirmed the downregulation of three high-interest candidate genes which are all components of the extracellular matrix: proteoglycan 4 (PRG4), fibulin-1 (FBLN-1) transcript variant D, and type XV collagen alpha 1 chain. Overall, our study has identified a variety of candidate genes that may be involved in the pathophysiology of Dupuytren's contracture and may ultimately serve as attractive molecular targets for alternative therapies.

1 February 2017 in Journal of Shoulder and Elbow Surgery
Verified
Journal Article
Closed access
SHScott Holmes
Scott Holmes
ADAna M. Pena Diaz
Ana M. Pena Diaz
GAGeorge S. Athwal
George S. Athwal
KFKenneth J. Faber
Kenneth J. Faber
DODavid B. O'GOrman
David B. O'GOrman

1 April 2017 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
PSPeter A Szabo
Peter A Szabo
AGAnkur Goswami
Ankur Goswami
DMDelfina M. Mazzuca
Delfina M. Mazzuca
KKKyoungok Kim
Kyoungok Kim
DODavid B. O’gorman
David B. O’gorman
SHS.M. Mansour Haeryfar
S.M. Mansour Haeryfar
Toxic shock syndrome (TSS) is caused by staphylococcal and streptococcal superantigens (SAgs) that provoke a swift hyperinflammatory response typified by a cytokine storm. The precipitous decline in the host’s clinical status and the lack of targeted therapies for TSS emphasize the need to identify key players of the storm’s initial wave. Using a humanized mouse model of TSS and human cells, we herein demonstrate that SAgs elicit in vitro and in vivo IL-17A responses within hours. SAg-triggered human IL-17A production was characterized by remarkably high mRNA stability for this cytokine. A distinct subpopulation of CD4+ effector memory T (TEM) cells that secrete IL-17A, but not IFN-γ, was responsible for early IL-17A production. We found mouse “TEM-17” cells to be enriched within the intestinal epithelium and among lamina propria lymphocytes. Furthermore, interfering with IL-17A receptor signaling in human PBMCs attenuated the expression of numerous inflammatory mediators implicated in the TSS-associated cytokine storm. IL-17A receptor blockade also abrogated the secondary effect of SAg-stimulated PBMCs on human dermal fibroblasts as judged by C/EBP δ expression. Finally, the early IL-17A response to SAgs was pathogenic because in vivo neutralization of IL-17A in humanized mice ameliorated hepatic and intestinal damage and reduced mortality. Together, our findings identify CD4+ TEM cells as a key effector of TSS and reveal a novel role for IL-17A in TSS immunopathogenesis. Our work thus elucidates a pathogenic, as opposed to protective, role for IL-17A during Gram-positive bacterial infections. Accordingly, the IL-17–IL-17R axis may provide an attractive target for the management of SAg-mediated illnesses.